Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 1
1994 1
1996 2
1997 2
1998 2
1999 3
2000 6
2002 4
2004 2
2005 3
2006 3
2007 3
2008 4
2009 2
2010 3
2011 3
2012 3
2013 5
2014 13
2015 3
2016 5
2017 9
2018 2
2019 6
2020 10
2021 10
2022 12
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Results by year

Filters applied: . Clear all
Page 1
Biobanking for COVID-19 research.
Rovere-Querini P, Tresoldi C, Conte C, Ruggeri A, Ghezzi S, DE Lorenzo R, DI Filippo L, Farina N, Ramirez GA, Ripa M, Mancini N, Cantarelli E, Galli L, Poli A, DE Cobelli F, Bonini C, Manfredi AA, Franchini S, Spessot M, Carlucci M, Dagna L, Scarpellini P, Ambrosio A, DI Napoli D, Bosi E, Tresoldi M, Lazzarin A, Landoni G, Martino G, Zangrillo A, Poli G, Castagna A, Vicenzi E, Clementi M, Ciceri F; COVID-BioB Study Group. Rovere-Querini P, et al. Panminerva Med. 2022 Jun;64(2):244-252. doi: 10.23736/S0031-0808.20.04168-3. Epub 2020 Oct 19. Panminerva Med. 2022. PMID: 33073557
The GR-ANXA1 pathway is a pathological player and a candidate target in epilepsy.
Zub E, Canet G, Garbelli R, Blaquiere M, Rossini L, Pastori C, Sheikh M, Reutelingsperger C, Klement W, de Bock F, Audinat E, Givalois L, Solito E, Marchi N. Zub E, et al. Among authors: pastori c. FASEB J. 2019 Dec;33(12):13998-14009. doi: 10.1096/fj.201901596R. Epub 2019 Oct 16. FASEB J. 2019. PMID: 31618599
Epigenetic pathways and glioblastoma treatment.
Clarke J, Penas C, Pastori C, Komotar RJ, Bregy A, Shah AH, Wahlestedt C, Ayad NG. Clarke J, et al. Among authors: pastori c. Epigenetics. 2013 Aug;8(8):785-95. doi: 10.4161/epi.25440. Epub 2013 Jun 27. Epigenetics. 2013. PMID: 23807265 Free PMC article. Review.
Epileptic phenotypes in autoimmune encephalitis: from acute symptomatic seizures to autoimmune-associated epilepsy.
Matricardi S, Casciato S, Bozzetti S, Mariotto S, Stabile A, Freri E, Deleo F, Sartori S, Nosadini M, Pappalardo I, Meletti S, Giovannini G, Zucchi E, Di Bonaventura C, Di Gennaro G, Ferrari S, Zuliani L, Zoccarato M, Vogrig A, Lattanzi S, Michelucci R, Gambardella A, Ferlazzo E, Fusco L, Granata T, Villani F; Immune Epilepsies Study Group of the Italian League Against Epilepsy. Matricardi S, et al. J Neurol Neurosurg Psychiatry. 2022 Jul 25:jnnp-2022-329195. doi: 10.1136/jnnp-2022-329195. Online ahead of print. J Neurol Neurosurg Psychiatry. 2022. PMID: 35879055
Adjunctive brivaracetam and sustained seizure frequency reduction in very active focal epilepsy.
Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Cerulli Irelli E, Chiesa V, Dainese F, De Maria G, Didato G, Di Gennaro G, Falcicchio G, Fanella M, Ferlazzo E, Gangitano M, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pizzanelli C, Pulitano P, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST (Brivaracetam Add‐On First Italian Network Study) Group Membership. Lattanzi S, et al. Epilepsia. 2023 Nov;64(11):2922-2933. doi: 10.1111/epi.17740. Epub 2023 Sep 9. Epilepsia. 2023. PMID: 38079181 Free article.
Adult-onset Rasmussen encephalitis treated with mitoxantrone.
Stabile A, Deleo F, Didato G, Pastori C, Antozzi C, de Curtis M, Villani F. Stabile A, et al. Among authors: pastori c. Eur J Neurol. 2018 Dec;25(12):e125-e126. doi: 10.1111/ene.13795. Eur J Neurol. 2018. PMID: 30403325 No abstract available.
Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, Real-World Study.
Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Cerulli Irelli E, Chiesa V, Dainese F, De Maria G, Didato G, Di Gennaro G, Falcicchio G, Fanella M, Ferlazzo E, Gangitano M, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pizzanelli C, Pulitano P, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST) Group. Lattanzi S, et al. Neurol Ther. 2022 Dec;11(4):1789-1804. doi: 10.1007/s40120-022-00402-3. Epub 2022 Sep 16. Neurol Ther. 2022. PMID: 36109431 Free PMC article.
120 results